Dr. Maynard Howe, as Stemedica Co-Founder and former Chief Executive Officer, brings a richly diverse background to the Company.  Along with his brother, Roger, he had previously launched five successful ventures in the medical device, software, testing and measurement, quality and consulting fields.  As Founder, Co-Chairman and CEO of Reliant Technologies, he led a team of scientists, engineers and physicians in developing, testing and launching the revolutionary medical laser for skin surgery known as Fraxel, an award winning medical laser technology that has resulted in defining a new category of science called fractional photothermolysis. This new science involves the role of lasers and the patient’s own stem cells in wound healing and derm/plastic surgery. The Fraxel laser, in conjunction with autologous and allogeneic stem cells, is currently being used in new clinical studies to treat scars, burn scars and diabetic ulcers. During his tenure at Reliant Technologies, the company achieved a strong intellectual property position with over 20 patents issued and 40 pending applications. In addition, Reliant had secured 13 FDA clearances, making it one of the premier market leaders with distribution in over 15 countries.

While at Reliant, Dr. Howe also led the team responsible for securing funding from individual and institutional investors including: Three Arch Partners, Pinnacle Venture Partners, Meritech Capital Partners, Delphi Ventures and Comerica Bank.  Within two months of filing its S1, Reliant was sold to Solta Medical, Inc., a publicly held company (SLTM) that has and continues to pioneer and define the aesthetic industry with its innovative technology.

Prior to Reliant, Dr. Howe helped more than fifty Fortune 500 companies coordinate their company-wide quality and customer relationship initiatives. As a senior executive and co-founder of a leading customer and market research company, he was responsible for conducting extensive marketing and branding campaigns, market assessments and trend research in both business-to-business and business-to-consumer environments. Maynard is also co-founder and previous Chairman of BioPharma Scientific, LLC, specializing in the integration of pharmaceutical nanotechnology into the field of nutraceuticals.

He has experience in setting up distribution and managing sales channels throughout North America, Europe and parts of Asia for several of the companies he has co-founded.

Maynard holds a Bachelor of Science Degree, Master of Science Degree and a Doctorate in Psychology. His ability to recruit world leaders and industry experts and create a culture of innovation and teamwork has contributed to the successes achieved in the businesses he has co-founded and those in which he has provided services as a board member and consultant.

Dr. Howe is the author and co-author of numerous articles and top selling business books. He is a nationally and internationally recognized speaker and lecturer. His benchmark book on quality, “Quality on Trial, Bringing Customer Relationships into Focus“, is in its second edition and has been published in several languages. His current book, which he is a co-author, “Miracle of Stem Cells: How Adult Stem Cells are Transforming Medicine“, is in its second printing and in the process of being translated into several languages. Other books include a five part implementation manual series, “Business to Business Marketing Management System“, published by McGraw-Hill.

He is a diplomate of the American College of Forensic Examiners and an active Board Member of the USO. Previously he was a Board Member and Chairman of the Advanced Development Committee for Alliant International University. Dr. Howe continues to Chair Doctoral Dissertations in Clinical Psychology and as well as in related Behavioral Science Fields.